-+ 0.00%
-+ 0.00%
-+ 0.00%

Chosa Oncology Enters Global Cross-Licensing Partnership With AIDA Oncology

PUBT·11/19/2026 07:36:38
Listen to the news
Chosa Oncology Enters Global Cross-Licensing Partnership With AIDA Oncology
  • Chosa Oncology entered a global, reciprocal, nonexclusive licensing partnership with AIDA Oncology on Aug. 27, 2026.
  • AIDA gained rights to use Platin-DRP in breast cancer; Chosa received rights to use TaxaTect in lung cancer.
  • The agreement includes undisclosed per-test fees.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Chosa Oncology AB published the original content used to generate this news brief on November 19, 2026, and is solely responsible for the information contained therein.